Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al
Case Number:
1:20-cv-00706
Court:
Nature of Suit:
Judge:
Firms
- Armstrong Teasdale
- Bennett Bricklin
- Calcagni & Kanefsky
- Chiesa Shahinian
- Crowell & Moring
- Dechert LLP
- DLA Piper
- Dorsey & Whitney
- Duane Morris
- Goodwin Procter
- Kang Haggerty
- Kasowitz Benson
- Kishner Miller
- Morgan Lewis
- Morgan Melhuish
- Obermayer Rebmann
- Phillips Nizer
- Sheppard Mullin
- Whiteford Taylor
- Wilson Sonsini
Companies
- Cardinal Health Inc.
- Cencora Inc.
- Cerovene Inc.
- Medisca Pharmaceutique Inc.
- Teva Pharmaceutical Industries Ltd.
- Vyera Pharmaceuticals LLC
Government Agencies
Sectors & Industries:
-
January 27, 2020
'Pharma Bro' Accused Of Monopolizing Life-Saving Drug
The Federal Trade Commission and New York's attorney general on Monday sued Martin Shkreli and a company he founded for allegedly monopolizing the market for a drug used to treat potentially fatal parasitic infections and dramatically hiking its price.